{
    "clinical_study": {
        "@rank": "19884", 
        "arm_group": [
            {
                "arm_group_label": "755nm Alexandrite Laser", 
                "arm_group_type": "Experimental", 
                "description": "755nm Alexandrite laser (standard handpiece)"
            }, 
            {
                "arm_group_label": "755nm Alexandrite laser with modified handpiec", 
                "arm_group_type": "Experimental", 
                "description": "Device: 755nm Alexandrite laser with modified handpiece"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate the safety and efficacy of the bilateral treatment of striae using a 755nm\n      Alexandrite laser."
        }, 
        "brief_title": "755nm Alex Laser for Treatment of Stretch Marks", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Striae", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          1. Is a healthy male or female between 18 and 85 years old.\n\n          2. Has unwanted striae and wishes to undergo laser treatments to remove or   improve\n             them.\n\n          3. Is willing to consent to participate in the study.\n\n          4. Is willing to comply with all requirements of the study including being\n             photographed, following post treatment care and attending all treatment and follow up\n             visits.\n\n        Exclusion Criteria\n\n          1. Is hypersensitive to light exposure.\n\n          2. Has active localized or systemic infection.\n\n          3. Is taking medication(s) for which sunlight is a contraindication.\n\n          4. Has a history of squamous cell carcinoma or melanoma.\n\n          5. Has a history of keloid scarring.\n\n          6. Has used oral isotretinoin (Accutane\u00ae) within 12 months of initial treatment or plans\n             on using during the course of the study. Note: Skin must regain its normal degree of\n             moisture prior to treatment.\n\n          7. Has a history of immunosuppression/immune deficiency disorders (including HIV\n             infection or AIDS) or use of immunosuppressive medications.\n\n          8. Is female and pregnant, has been pregnant within the last 3 months, is currently\n             breast feeding or planning a pregnancy during the study period.\n\n          9. Is allergic to lidocaine, tetracaine or Xylocaine with epinephrine.\n\n         10. Has any other reason determined by the physician to be ineligible to participate in\n             the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01745211", 
            "org_study_id": "CYN12-PICO-STRIAE_RG4"
        }, 
        "intervention": {
            "arm_group_label": [
                "755nm Alexandrite Laser", 
                "755nm Alexandrite laser with modified handpiec"
            ], 
            "description": "755nm Alexandrite laser with modified and standard handpiece", 
            "intervention_name": "755nm Alexandrite Laser", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10016"
                }, 
                "name": "Laser & Skin Surgery Center of New York"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patricia Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "both standard and 3D photography will be used", 
            "measure": "Photographic evaluation of striae clearance", 
            "safety_issue": "No", 
            "time_frame": "up to 3 months post last treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01745211"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}